BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18665584)

  • 21. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues.
    Terentis AC; Freewan M; Sempértegui Plaza TS; Raftery MJ; Stocker R; Thomas SR
    Biochemistry; 2010 Jan; 49(3):591-600. PubMed ID: 20000778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
    Yang S; Li X; Hu F; Li Y; Yang Y; Yan J; Kuang C; Yang Q
    J Med Chem; 2013 Nov; 56(21):8321-31. PubMed ID: 24099220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of 5-(N-hydroxycarbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Jung J; Yoon H; Sohn TI; Jang K; Yoo Y; Jeong I; Shin JE; Lee JH; Ann J; Lee J
    Bioorg Med Chem Lett; 2021 May; 40():127963. PubMed ID: 33741464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.
    Smith JR; Evans KJ; Wright A; Willows RD; Jamie JF; Griffith R
    Bioorg Med Chem; 2012 Feb; 20(3):1354-63. PubMed ID: 22112538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors.
    Yang R; Chen Y; Pan L; Yang Y; Zheng Q; Hu Y; Wang Y; Zhang L; Sun Y; Li Z; Meng X
    Bioorg Med Chem; 2018 Sep; 26(17):4886-4897. PubMed ID: 30170925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy.
    Lin SY; Yeh TK; Song JS; Hung MS; Cheng MF; Liao FY; Li AS; Cheng SY; Lin LM; Chiu CH; Wu MH; Lin YJ; Hsiao W; Sun M; Wang YH; Huang CH; Tang YC; Chang HH; Huang ZT; Chao YS; Shih C; Pan SL; Wu SY; Kuo CC; Ueng SH
    Bioorg Chem; 2018 Apr; 77():600-607. PubMed ID: 29494816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic study of imidazoles inhibiting IDO1 via the integration of molecular mechanics and quantum mechanics calculations.
    Zou Y; Wang F; Wang Y; Guo W; Zhang Y; Xu Q; Lai Y
    Eur J Med Chem; 2017 May; 131():152-170. PubMed ID: 28319781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.
    Gao D; Li Y
    Bioorg Med Chem; 2017 Jul; 25(14):3780-3791. PubMed ID: 28526475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase.
    Sugimoto H; Oda S; Otsuki T; Hino T; Yoshida T; Shiro Y
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2611-6. PubMed ID: 16477023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory investigation of niacin derivatives on metalloenzyme indoleamine 2,3-dioxygenase 1 for its immunomodulatory function.
    Yan D; Xu J; Tan X
    Metallomics; 2021 Feb; 13(3):. PubMed ID: 33638642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research progress of indoleamine 2,3-dioxygenase inhibitors.
    Jiang T; Sun Y; Yin Z; Feng S; Sun L; Li Z
    Future Med Chem; 2015; 7(2):185-201. PubMed ID: 25686005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and biological evaluation of 2,5-dimethylfuran-3-carboxylic acid derivatives as potential IDO1 inhibitors.
    Yang X; Cai S; Liu X; Chen P; Zhou J; Zhang H
    Bioorg Med Chem; 2019 Apr; 27(8):1605-1618. PubMed ID: 30858027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel imidazoles as IDO1 inhibitors through microwave-assisted one-pot multicomponent reactions.
    Bai Z; Huang H; Chen J; Zhang X; Ding Y
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900165. PubMed ID: 31482583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate.
    Crosignani S; Bingham P; Bottemanne P; Cannelle H; Cauwenberghs S; Cordonnier M; Dalvie D; Deroose F; Feng JL; Gomes B; Greasley S; Kaiser SE; Kraus M; Négrerie M; Maegley K; Miller N; Murray BW; Schneider M; Soloweij J; Stewart AE; Tumang J; Torti VR; Van Den Eynde B; Wythes M
    J Med Chem; 2017 Dec; 60(23):9617-9629. PubMed ID: 29111717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of novel tryptoline derivatives as indoleamine 2,3-dioxygenase (IDO) inhibitors.
    Tanaka M; Li X; Hikawa H; Suzuki T; Tsutsumi K; Sato M; Takikawa O; Suzuki H; Yokoyama Y
    Bioorg Med Chem; 2013 Mar; 21(5):1159-65. PubMed ID: 23337802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase.
    Matsuno K; Takai K; Isaka Y; Unno Y; Sato M; Takikawa O; Asai A
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5126-9. PubMed ID: 20688518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and optimization of a novel series of indoleamine 2,3-dioxygenase inhibitors.
    Markwalder JA; Seitz SP; Blat Y; Elkin L; Hunt JT; Pabalan JG; Jure-Kunkel MN; Vite GD; Covello K
    Bioorg Med Chem Lett; 2017 Feb; 27(3):582-585. PubMed ID: 28003141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unique Sulfur-Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors.
    Peng YH; Liao FY; Tseng CT; Kuppusamy R; Li AS; Chen CH; Fan YS; Wang SY; Wu MH; Hsueh CC; Chang JY; Lee LC; Shih C; Shia KS; Yeh TK; Hung MS; Kuo CC; Song JS; Wu SY; Ueng SH
    J Med Chem; 2020 Feb; 63(4):1642-1659. PubMed ID: 31961685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular docking and dynamic simulation studies evidenced plausible immunotherapeutic anticancer property by Withaferin A targeting indoleamine 2,3-dioxygenase.
    Reddy SV; Reddy KT; Kumari VV; Basha SH
    J Biomol Struct Dyn; 2015; 33(12):2695-709. PubMed ID: 25671592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1.
    Jiang S; Li H; Piao L; Jin Z; Liu J; Chen S; Liu LL; Shao Y; Zhong S; Wu B; Li W; Ren J; Zhang Y; Wang H; Jin R
    Aging (Albany NY); 2020 Jun; 12(12):11349-11363. PubMed ID: 32568737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.